National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI)
HL19278
米国
National Institutes of Health/National Center for Advancing Translational Sciences (NIH/NCATS)
UL1 TR001866
米国
National Science Foundation (NSF, United States)
ACI-1053575
米国
引用
ジャーナル: Arterioscler Thromb Vasc Biol / 年: 2020 タイトル: Cryo-Electron Microscopy Structure of the αIIbβ3-Abciximab Complex. 著者: Dragana Nešić / Yixiao Zhang / Aleksandar Spasic / Jihong Li / Davide Provasi / Marta Filizola / Thomas Walz / Barry S Coller 要旨: OBJECTIVE: The αIIbβ3 antagonist antiplatelet drug abciximab is the chimeric antigen-binding fragment comprising the variable regions of murine monoclonal antibody 7E3 and the constant domains of ...OBJECTIVE: The αIIbβ3 antagonist antiplatelet drug abciximab is the chimeric antigen-binding fragment comprising the variable regions of murine monoclonal antibody 7E3 and the constant domains of human IgG1 and light chain κ. Previous mutagenesis studies suggested that abciximab binds to the β3 C177-C184 specificity-determining loop (SDL) and Trp129 on the adjacent β1-α1 helix. These studies could not, however, assess whether 7E3 or abciximab prevents fibrinogen binding by steric interference, disruption of either the αIIbβ3-binding pocket for fibrinogen or the β3 SDL (which is not part of the binding pocket but affects fibrinogen binding), or some combination of these effects. To address this gap, we used cryo-electron microscopy to determine the structure of the αIIbβ3-abciximab complex at 2.8 Å resolution. Approach and Results: The interacting surface of abciximab is comprised of residues from all 3 complementarity-determining regions of both the light and heavy chains, with high representation of aromatic residues. Binding is primarily to the β3 SDL and neighboring residues, the β1-α1 helix, and β3 residues Ser211, Val212 and Met335. Unexpectedly, the structure also indicated several interactions with αIIb. As judged by the cryo-electron microscopy model, molecular-dynamics simulations, and mutagenesis, the binding of abciximab does not appear to rely on the interaction with the αIIb residues and does not result in disruption of the fibrinogen-binding pocket; it does, however, compress and reduce the flexibility of the SDL. CONCLUSIONS: We deduce that abciximab prevents ligand binding by steric interference, with a potential contribution via displacement of the SDL and limitation of the flexibility of the SDL residues.
ムービー
コントローラー
データを開く
基本情報
マップデータ
試料
キーワード
機能・相同性情報
Homo sapiens (ヒト) / synthetic construct (人工物)
データ登録者
米国, 3件 
引用
構造の表示
ダウンロードとリンク
emd_21044.png
http://ftp.pdbj.org/pub/emdb/structures/EMD-21044
Z (Sec.)
Y (Row.)
X (Col.)
試料の構成要素
解析
電子顕微鏡法
FIELD EMISSION GUN
